Bintayan, Norie .

HRN: 22-70-87  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/14/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/14/2023
03/15/2023
IVT
4.5g
Q8 Hours
Sepsis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: